BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 5545268)

  • 1. The effect of L-asparaginase on mitotic activity during N-2-fluorenylacetamide hepatocarcinogenesis: subpopulations of nodular cells.
    Becker FF; Klein KM
    Cancer Res; 1971 Feb; 31(2):169-73. PubMed ID: 5545268
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined enzyme histochemical and radioautographic studies on areas of hyperplasia in the liver of rats fed N-2-fluorenylacetamide.
    Kitagawa T; Sugano H
    Cancer Res; 1973 Nov; 33(11):2993-3001. PubMed ID: 4355988
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitotic, chromosomal, and nucleolar alterations induced by thioacetamide in relation to the mitotic cycle after partial hepatectomy.
    Mironescu S; Clovîrnache M
    J Natl Cancer Inst; 1971 Jan; 46(1):49-61. PubMed ID: 4100558
    [No Abstract]   [Full Text] [Related]  

  • 4. The synergistic effect of hypoglycemia and L-asparaginase upon transplantable hepatomas of varying growth rates.
    Becker FF; Klein KM
    Cancer Res; 1972 Oct; 32(10):2082-4. PubMed ID: 4343006
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of L-asparaginase on DNA synthesis in regenerating liver and in other dividing tissues.
    Becker FF; Baserga R; Broome JD
    Cancer Res; 1970 Jan; 30(1):133-7. PubMed ID: 5458958
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular analysis of liver carcinogenesis. 3. Comparison of the ultrastructure of hyperplastic liver nodules and hepatocellular carcinomas induced in rat liver by 2-fluorenylacetamide.
    Merkow LP; Epstein SM; Farber E; Pardo M; Bartus B
    J Natl Cancer Inst; 1969 Jul; 43(1):33-63. PubMed ID: 4307705
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene.
    Peraino C; Fry RJ; Staffeldt E
    Cancer Res; 1971 Oct; 31(10):1506-12. PubMed ID: 4328739
    [No Abstract]   [Full Text] [Related]  

  • 8. Alteration of the ability of liver microsomes to activate N-2-fluorenylacetamide to a mutagen of Salmonella typhimurium during hepatocarcinogenesis.
    Stout DL; Becker FF
    Cancer Res; 1978 Aug; 38(8):2274-8. PubMed ID: 208764
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased selectivity of interaction between fluorenylamine carcinogens and liver proteins during hepatocarcinogenesis.
    Sorof S; Young EM; McBride RZ; Coffey CB; Luongo L
    Mol Pharmacol; 1969 Nov; 5(6):625-39. PubMed ID: 5373894
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of orotic acid on liver tumorigenesis in rats ingesting ethionine, N-2-fluorenylacetamide, and 3'-methyl-dimethylaminoazobenzene.
    Sidransky H; Verney E
    J Natl Cancer Inst; 1970 May; 44(5):1201-15. PubMed ID: 5514477
    [No Abstract]   [Full Text] [Related]  

  • 11. Chromosome patterns in rat hepatocytes during N-2-fluorenylacetamide carcinogenesis.
    Becker FF; Fox RA; Klein KM; Wolman SR
    J Natl Cancer Inst; 1971 Jun; 46(6):1261-9. PubMed ID: 4325934
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination of enzyme histochemistry and radioautography: a new method applied to analysis of hepatocarcinogenesis.
    Kitagawa T; Sugano H
    Gan; 1972 Aug; 63(4):509. PubMed ID: 5081629
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of liver regeneration on the loss of fluorenylacetamide derivative bound to liver DNA.
    Witschi H; Epstein SM; Farber E
    Cancer Res; 1971 Mar; 31(3):270-3. PubMed ID: 5547215
    [No Abstract]   [Full Text] [Related]  

  • 14. Early elevation of alpha 1-fetoprotein in N-2-fluorenylacetamide hepatocarcinogenesis.
    Becker FF; Sell S
    Cancer Res; 1974 Oct; 34(10):2489-94. PubMed ID: 4412886
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell loss and proliferation induced by N-2-fluorenylacetamide in the rat liver in relation to hepatoma induction.
    Albert RE; Burns FJ; Bilger L; Gardner D; Troll W
    Cancer Res; 1972 Oct; 32(10):2172-7. PubMed ID: 4343011
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of 2-acetylaminofluorene on liver cell proliferation after partial hepatectomy of female rats.
    Jackson CD; Irving CC
    Cancer Res; 1973 Feb; 33(2):397-401. PubMed ID: 4688886
    [No Abstract]   [Full Text] [Related]  

  • 17. Mitotic blockage at G2 after partial hepatectomy during 4-dimethylaminoazobenzene hepatocarcinogenesis.
    Banerjee MR
    J Natl Cancer Inst; 1965 Oct; 35(4):585-9. PubMed ID: 4953914
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism.
    Epstein S; Ito N; Merkow L; Farber E
    Cancer Res; 1967 Sep; 27(9):1702-11. PubMed ID: 4293077
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of p-hydroxyacetanilide on liver cancer induction by N hydroxy-N-2-fluorenylacetamide.
    Yamamoto RS; Williams GM; Richardson HL; Weisburger EK; Weisburger JH
    Cancer Res; 1973 Mar; 33(3):454-7. PubMed ID: 4347712
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver regeneration and induction of hepatomas in B6AF mice by urethan.
    Chernozemski IN; Warwick GP
    Cancer Res; 1970 Nov; 30(11):2685-90. PubMed ID: 4321085
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.